Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
Titel:
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
Auteur:
Laukhtina, Ekaterina Quhal, Fahad Mori, Keiichiro Sari Motlagh, Reza Rajwa, Pawel Yanagisawa, Takafumi Mostafaei, Hadi König, Frederik Aydh, Abdulmajeed Pradere, Benjamin Enikeev, Dmitry Karakiewicz, Pierre I. Schmidinger, Manuela Shariat, Shahrokh F.